Steritas
At Steritas, we understand the devastating impact that steroid treatment can have on patients around the world. Tracking steroid-toxicity with the STOX® Suite of clinical outcome assessments provides clinicians with the means to taper steroid usage, optimize treatment and improve outcomes for patients. Our expanding suite of clinical outcome assessments is driving the development of new steroid-sparing therapies through their use in clinical trials. To date, the suite has been used in over 80 clinical trials around the world.Content by Steritas
| 6 min read
Efforts to move beyond long-term steroid use are accelerating, with growing awareness of steroid toxicity, new tools to guide tapering, and emerging therapies offering safer alternatives.
Page 1 of 1 - 1 Total Items
